AUPR644301A0 - Method and composition for treatment of cancer - Google Patents

Method and composition for treatment of cancer

Info

Publication number
AUPR644301A0
AUPR644301A0 AUPR6443A AUPR644301A AUPR644301A0 AU PR644301 A0 AUPR644301 A0 AU PR644301A0 AU PR6443 A AUPR6443 A AU PR6443A AU PR644301 A AUPR644301 A AU PR644301A AU PR644301 A0 AUPR644301 A0 AU PR644301A0
Authority
AU
Australia
Prior art keywords
cancer
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR6443A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Priority to AUPR6443A priority Critical patent/AUPR644301A0/en
Publication of AUPR644301A0 publication Critical patent/AUPR644301A0/en
Priority to BR0211436-4A priority patent/BR0211436A/pt
Priority to CNA028157109A priority patent/CN1551771A/zh
Priority to JP2003513564A priority patent/JP2004536857A/ja
Priority to KR10-2004-7000795A priority patent/KR20040038984A/ko
Priority to US10/467,618 priority patent/US20040067952A1/en
Priority to CA002453993A priority patent/CA2453993A1/en
Priority to PCT/AU2002/000954 priority patent/WO2003007957A1/en
Priority to MXPA04000518A priority patent/MXPA04000518A/es
Priority to EP02748440A priority patent/EP1423118A4/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AUPR6443A 2001-07-17 2001-07-17 Method and composition for treatment of cancer Abandoned AUPR644301A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPR6443A AUPR644301A0 (en) 2001-07-17 2001-07-17 Method and composition for treatment of cancer
EP02748440A EP1423118A4 (en) 2001-07-17 2002-07-16 METHOD AND COMPOSITION FOR CANCER TREATMENT
KR10-2004-7000795A KR20040038984A (ko) 2001-07-17 2002-07-16 암 치료 방법 및 암 치료용 조성물
CNA028157109A CN1551771A (zh) 2001-07-17 2002-07-16 用于治疗癌症的方法和组合物
JP2003513564A JP2004536857A (ja) 2001-07-17 2002-07-16 癌の治療のための方法及び組成物
BR0211436-4A BR0211436A (pt) 2001-07-17 2002-07-16 Método e composição para tratamento de câncer
US10/467,618 US20040067952A1 (en) 2001-07-17 2002-07-16 Method and composition for treatment of cancer
CA002453993A CA2453993A1 (en) 2001-07-17 2002-07-16 Method and composition for treatment of cancer
PCT/AU2002/000954 WO2003007957A1 (en) 2001-07-17 2002-07-16 Method and composition for treatment of cancer
MXPA04000518A MXPA04000518A (es) 2001-07-17 2002-07-16 Metodo y composicion para el tratamiento de cancer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6443A AUPR644301A0 (en) 2001-07-17 2001-07-17 Method and composition for treatment of cancer

Publications (1)

Publication Number Publication Date
AUPR644301A0 true AUPR644301A0 (en) 2001-08-09

Family

ID=3830401

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR6443A Abandoned AUPR644301A0 (en) 2001-07-17 2001-07-17 Method and composition for treatment of cancer

Country Status (10)

Country Link
US (1) US20040067952A1 (enExample)
EP (1) EP1423118A4 (enExample)
JP (1) JP2004536857A (enExample)
KR (1) KR20040038984A (enExample)
CN (1) CN1551771A (enExample)
AU (1) AUPR644301A0 (enExample)
BR (1) BR0211436A (enExample)
CA (1) CA2453993A1 (enExample)
MX (1) MXPA04000518A (enExample)
WO (1) WO2003007957A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4763681B2 (ja) * 2004-03-05 2011-08-31 ベニテック インコーポレイテッド ＲＮＡｉ作用媒介物の同時デリバリーのためのマルチプロモーター発現カセット
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
KR20140051555A (ko) * 2012-10-23 2014-05-02 씨지케이바이오 주식회사 전립선암 예방 및 치료용 약학 조성물
CN103360329B (zh) * 2013-07-18 2015-11-18 中国科学院南海海洋研究所 一类吩嗪化合物及其在制备抗肿瘤药物中的应用
BR112018003232A2 (pt) * 2015-10-06 2018-09-25 Redhill Biopharma Ltd terapias de combinação para tratamento de câncer
WO2019060409A1 (en) * 2017-09-19 2019-03-28 The Cleveland Clinic Foundation INHIBITION OF CONNEXIN 46 TO TREAT A GLIOBLASTOMA AND OTHER STATES
CN119564691A (zh) * 2024-12-13 2025-03-07 首都医科大学附属北京佑安医院 氯法齐明在制备治疗癌症的药物中的应用
CN119700770A (zh) * 2025-01-09 2025-03-28 首都医科大学附属北京佑安医院 氯法齐明在制备修复肠黏膜或改善肠道菌群药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
JPS6296A (ja) * 1985-03-06 1987-01-06 Sumitomo Pharmaceut Co Ltd 脂溶性白金（２）錯体
EP0280741B1 (en) * 1986-08-29 1994-12-07 Kyowa Hakko Kogyo Kabushiki Kaisha Mitomycin derivatives
ZA928419B (en) * 1991-11-29 1994-03-01 Univ Pretoria Pharmaceutical substances or compositions and their use
US5763443A (en) * 1994-04-05 1998-06-09 Universiteit Van Pretoria MDR resistance treatment and novel pharmaceutically active riminophenazines
DE69528103T2 (de) * 1994-04-05 2003-05-15 Universiteit Van Pretoria, Gauteng Verwendung von Riminophenazin zur Behandlung von MDR-Resistenz
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
AUPP332898A0 (en) * 1998-05-04 1998-05-28 Unisearch Limited Pharmaceutical composition

Also Published As

Publication number Publication date
EP1423118A1 (en) 2004-06-02
JP2004536857A (ja) 2004-12-09
CN1551771A (zh) 2004-12-01
BR0211436A (pt) 2004-07-13
US20040067952A1 (en) 2004-04-08
EP1423118A4 (en) 2006-03-22
WO2003007957A1 (en) 2003-01-30
KR20040038984A (ko) 2004-05-08
CA2453993A1 (en) 2003-01-30
MXPA04000518A (es) 2005-03-07

Similar Documents

Publication Publication Date Title
AUPR638101A0 (en) Composition and method for treatment of disease
AU2002364364A1 (en) Method of treating apoptosis and compositions thereof
AU2003226301A1 (en) Method of treating cancer
AU2003230750A1 (en) Compositions and methods for treating cancer
AU2003256847A1 (en) Method of treating cancer
AU2002328952A1 (en) Irinotecan for treatment of cancer
AU2003225535A1 (en) Methods and compositions for treating cancer
EP1379242A4 (en) METHOD OF TREATING CANCERS AND APPROPRIATE COMPOSITIONS
IL145397A0 (en) Compositions and methods for treatment of cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
AUPR731901A0 (en) Method of treatment
AU2001253836A1 (en) Method of treating cancer
AU2003280558A1 (en) Method for treatment of cancer
AUPR644301A0 (en) Method and composition for treatment of cancer
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2002305823A1 (en) Cancer treatment method and compositions comprising compounds of the ginger family
GB2399500B (en) Composition and method for treatment of wounds
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2002360454A1 (en) Methods and compositions for treating cancer
AU2003272972A1 (en) Method of treatment for cancer
AU1471300A (en) Compositions and methods for treatment of cancer
AUPR434501A0 (en) Composition and method of treatment
AU2003272973A1 (en) Method for treatment of cancer
AU2003295604A1 (en) Gpc15: methods and compositions for treating cancer
AU2002324724A1 (en) Compositions and methods for the treatment of cancer